Combination Medications vs. Patch Alone for Medically-Ill Smokers

Completed · Phase 4

Conditions studied: Smoking Cessation

In brief

Randomized clinical trial to evaluate a flexibly-dosed-3-medication combination for up to 6 months in smokers with medical illness

Key facts

Study ID

NCT00770666

Run by

University of Medicine and Dentistry of New Jersey

People needed

127

Starts

2005-09-01

Expected to finish

2008-01-01

Last updated by the study team

2008-10-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• currently smoking at least 10 cigarettes per day (confirmed by high exhaled carbon-monoxide (CO))
• 18 years or older
• interested in quitting within the next 30 days
• one or more pre-defined medical illnesses (including cardiovascular disease, other vascular disease, chronic pulmonary disease, cancer, hypertension, diabetes, hyperlipidemia, and recurrent pulmonary infections)

You may not qualify if…

• contraindications to pharmacotherapy (including unstable angina, myocardial infarction within 2 months, severe arrhythmia, seizure disorder, serious mental illness requiring antipsychotic medications)
• current use of other tobacco products (smokeless tobacco, cigars, pipes, etc.), bupropion, clonidine, nortriptyline, or nicotine replacement medications
• unable to give consent

Where it is running

• Umdnj-Rwjms — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.